50268-682 : Prax 10 mg/ml Topical Lotion


NDC50268-682
Labeler: Avpak
Product Type: Human OTC Drug
Drug Name:  Prax
Dosage Form: Topical Lotion
Application #: part346
Rev. Date: 


NDC Package Codes:

  • 50268-682-15: 237 ML IN 1 BOTTLE (50268‑682‑15)

Active Ingredients:

  • Pramoxine Hydrochloride

Dosage Strength:

  • 10 mg/mL

Related Products:

Based on records with the same trade name.
  • 0496-0741 Prax 10 mg/g Topical Cloth by Ferndale Laboratories, Inc.
  • 0496-0748 Prax 10 mg/ml Topical Lotion by Ferndale Laboratories, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50268-682 QR Code

< Prev: 50268-681Next: 50268-683 >

Related Discussions:

Pramoxine by Acella versus Pramoxine by Perrigo
I have been prescribed Pramoxine (Pramasone) for my dermatillomania (facial sores). I had been using the cream but the p... 1 reply
prax 5mg medicine
prax 5mg details ## I am 54 years old. ## Were you referring to the medication Pax? If so, it contains the active ingred... 2 replies
praxidep cr, gabapin nt
. Dr prescribed me gabapin nt and praxidep cr for undiagonised rectal pain and spine legs pain fatigue. Earlier I took g...
pramoxine hci
does this contain alcohol? ## same ingredient in neosporin and tucks(this one has benzyl benozoate.... 1 reply
pramoxine hcl
If Pramoxine is used in a cattle hoof spray at 0.2 to 1.0 % what FDA regulations apply...
FDA regs for pramoxine hcl
following up early request for info. on FDAregs for Pramoxine...
Prax 10 Side Effects
I had a stent put in 2 years ago & have been on the following medication for BP, cholesterol, & blood thinners: ... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.